medigraphic.com
ISSN 0035-0052 (Print)

2021, Number 3

Next >>

Rev Mex Pediatr 2021; 88 (3)

COVID-19 vaccination in children

Aragón-Nogales R, Miranda-Novales MG

Language: Spanish
References: 20
Page: 89-92
PDF size: 206.51 Kb.





REFERENCES

  1. Weekly epidemiological update on COVID-19 - 17 August 2021 [Internet]. Available in: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---17-august-2021

  2. Borrelli M, Corcione A, Castellano F, Fiori Nastro F, Santamaria F. Coronavirus disease 2019 in children. Front Pediatr. 2021; 9: 668484.

  3. Children and COVID-19: State-Level Data Report [Internet]. Available in: http://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/

  4. Datos abiertos. Dirección General de Epidemiología. Disponible en: https://www.gob.mx/salud/documentos/datos-abiertos-152127

  5. The Access to COVID-19 Tools (ACT) Accelerator [Internet]. Available in: https://www.who.int/initiatives/act-accelerator

  6. Shrotri M, Swinnen T, Kampmann B, Parker EPK. An interactive website tracking COVID-19 vaccine development. Lancet Glob Health. 2021; 9(5): e590-e592.

  7. COVID-19 vaccine tracker [Internet]. Available in: https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/

  8. Organización Mundial de la Salud. ?Hoja de ruta del SAGE de la OMS para el establecimiento de prioridades en el uso de vacunas contra la COVID-19 en un contexto de suministros limitados: conjunto de criterios para orientar la planificación y las recomendaciones posteriores en distintos contextos epidemiológicos y posibles situaciones de suministro de vacunas, 20 de octubre de 2020, Versión 1. Organización Mundial de la Salud; 2020. Disponible en: https://apps.who.int/iris/handle/10665/341447

  9. Enfermedad por el coronavirus (COVID-19): Vacunas [Internet]. Disponible en: https://www.who.int/es/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines

  10. Covid-19 GTA de V. Priorización inicial y consecutiva para la vacunación contra SARS-CoV-2 en la población mexicana. Recomendaciones preliminares. Salud Pública Méx. 2021; 63(2): 288-309.

  11. Kampmann B, Okomo U. COVID-19 vaccines for children in LMICs: another equity issue. Lancet (London, England) [Internet]. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324110/

  12. Frenck RW, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, et al. Safety, Immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med. 2021; 385: 239-250.

  13. Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021; S1473-3099(21)00319-4.

  14. Ali K, Berman G, Zhou H, Deng W, Faughnan V, Coronado-Voges M, et al. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. N Engl J Med. 2021. doi: 10.1056/NEJMoa2109522.

  15. Zou X, Cao B. COVID-19 vaccines for children younger than 12 years: are we ready? Lancet Infect Dis. 2021; S1473-3099(21)00384-4.

  16. JCVI statement on COVID-19 vaccination of children and young people aged 12 to 17 years: 4 August 2021 [Internet]. GOV.UK. Available in: https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years/jcvi-statement-on-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years-4-august-2021

  17. Hause AM. COVID-19 vaccine safety in adolescents aged 12-17 Years - United States, December 14, 2020–July 16, 2021. MMWR Morb Mortal Wkly Rep [Internet]. 2021; 70. Available in: https://www.cdc.gov/mmwr/volumes/70/wr/mm7031e1.htm

  18. Gargano JW. Use of mRNA COVID-19 Vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices - United States, June 2021. MMWR Morb Mortal Wkly Rep [Internet]. 2021; 70(27): 977-982. Available in: https://www.cdc.gov/mmwr/volumes/70/wr/mm7027e2.htm

  19. Secretaría de Salud. Informes Epidemiológicos de la situación de COVID19 en México 2021 [Internet]. gob.mx. Disponible en: http://www.gob.mx/salud/documentos/informes-epidemiologicos-de-la-situacion-de-covid19-en-mexico-2021?idiom=es

  20. COFEPRIS emite modificación a la autorización para uso de emergencia de vacuna pfizer-biontech; permitirá aplicación a partir de 12 años [Internet]. gob.mx. Disponible en: http://www.gob.mx/cofepris/articulos/cofepris-emite-modificacion-a-la-autorizacion-para-uso-de-emergencia-de-vacuna-pfizer-biontech-permitira-aplicacion-a-partir-de-12-anos?idiom=es




2020     |     www.medigraphic.com